Ovulation in hypothalamic amenorrhea, subQ pump (trial)
Timing and details
Loading…
Also known as: GnRH · LHRH · Gonadotropin-releasing hormone · Gonadorelin acetate · Gonadorelin hydrochloride · Factrel · Lutrepulse
Updated 21 sources
How it is thought to work. Gonadorelin has the same 10-amino-acid sequence as natural GnRH. It binds GnRH receptors on the pituitary and releases LH and FSH, which drive testosterone and sperm in men and ovulation in women. The body expects GnRH in pulses about every 1.5 to 2 hours. Pulses stimulate the axis; constant exposure shuts it down, which is how long-acting GnRH agonists like leuprolide suppress hormones.
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Doses shown are what sources report, labelled by origin. Not medical advice.
Full Gonadorelin dosage guideEvery titration step in syringe units, missed doses and how to mix.| Water | Strength | 50 mcgdose, units | 100 mcgdose, units | 200 mcgdose, units |
|---|---|---|---|---|
| 2 mg vial | ||||
| 2 mLCompetitor guide | 1 mg/mL | 50.05 mL | 100.1 mL | 200.2 mL |
| 5 mg vial | ||||
| 1 mLCompetitor guide† | 5 mg/mL | 10.01 mL | 20.02 mL | 40.04 mL |
| 2 mLCompetitor guide† | 2.5 mg/mL | 20.02 mL | 40.04 mL | 80.08 mL |
| 10 mg vial | ||||
| 1 mLCompetitor guide | 10 mg/mL | 0.50.005 mLunder 1 unit | 10.01 mL | 20.02 mL |
| 2 mLCompetitor guide | 5 mg/mL | 10.01 mL | 20.02 mL | 40.04 mL |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: Gonadorelin in syringe units, with the math shown.From clinical trials and regulatory documents.
Rare after a single 100 mcg dose, per the Factrel label.
Rare after a single 100 mcg dose, per the Factrel label.
Rare after a single dose, per the Factrel label.
May occur after subcutaneous use, per the Factrel label; no rate given.
How people manage it
Local and generalized rashes noted after chronic subcutaneous use, per the label.
Rare, reported after repeated doses, per the Factrel label.
How people manage it
From community reports and dosing guides. Not measured rates.
One site's logs: nausea 2, injection-site irritation 2, headache 1, out of 25 reports.
Some TRT users report their testes still shrank on gonadorelin; others report it held. No numbers.
Allergy to gonadorelinCondition
The only contraindication on the Factrel label.
Gonadotropin-secreting pituitary tumorCondition
The label cites a report of pituitary apoplexy and sudden blindness after GnRH in a patient with this kind of adenoma.
Drug-tested sportCondition
WADA's 2026 Prohibited List bans GnRH (gonadorelin) and its agonist analogues in male athletes (S2.2.1).
Factrel vials: room temperature, about 25 C.
Research vials: guides say fridge (2 to 8 C) or freezer (-20 C), protected from light.
Mixed research vials: 2 to 8 C, do not freeze. Guides give 14 days or 28 days.
Factrel label: mix right before use, keep at room temperature, use within 1 day.
Mixed with: Bacteriostatic water (Factrel came with 2% benzyl alcohol in sterile water)
Mixing. A 2 mg vial in 2 mL gives 1 mg per mL, so 100 mcg is 10 units on a U-100 syringe. One calculator site mislabels its 10 mg in 1 mL default as 5 mg per mL; check the math for your own vial.
Some TRT users pair gonadorelin with low-dose hCG for fertility, per community summaries. hCG acts on the testes directly; gonadorelin needs a working pituitary.
Kisspeptin releases the body's own GnRH and gonadorelin is GnRH, so users stack them for two-level axis stimulation. Untested as a pair.
Overlap, not synergy: retatrutide is the compound most often logged alongside gonadorelin on one site, with tesamorelin second.
Strong history for what it was approved for: a one-dose pituitary test, and pulsatile pumps that restore fertility in hypogonadotropic hypogonadism (for example 54 men in a 2025 study, 28 in 2019 and 2024 studies). For the popular use, 100 to 200 mcg shots a few times a week on TRT, we found no controlled human study.
Approved by the FDA, but for a narrower use than people take it for here.
FDA approved gonadorelin as Factrel (1982, a pituitary function test) and Lutrepulse (1989, a fertility pump). Drugs@FDA lists both as discontinued, a marketing status, and shows no withdrawal of either approval. TRT use was never approved. It is not on the 503A category lists; the 503B nominations list has gonadorelin acetate in Category 1. A veterinary Factrel is approved for cattle.
Human gonadorelin now reaches US patients through compounding pharmacies, and research vials are sold separately. FDA marks gonadorelin acetate on its 503B list as a component of an FDA-approved drug. WADA's 2026 list names GnRH (gonadorelin) and its agonist analogues under S2.2.1, testosterone-stimulating peptides in males.
WADA: Prohibited
Synthetic GnRH, identical to the hormone the hypothalamus releases to make the pituitary put out LH and FSH. It was sold as Factrel and Lutrepulse; today it mostly reaches people through compounding pharmacies and research vials.
Guides and community summaries cluster at 100 to 200 mcg under the skin, 2 to 3 times a week, for as long as TRT runs. Some clinics use 50 to 100 mcg. No trial has tested any of these doses in men on TRT.
For the Factrel pituitary test, 100 mcg once, under the skin or IV, with blood drawn over the next 2 hours. For fertility, pumps gave about 5 to 20 mcg every 90 to 120 minutes.
Yes, for narrow uses that are off the market. Factrel (1982) and Lutrepulse (1989) were approved, and Drugs@FDA now lists both as discontinued without showing any withdrawal of the approvals. TRT use was never approved. A veterinary Factrel for cattle is still an approved animal drug, and compounding pharmacies still make gonadorelin.
It is the most common reason TRT users take it. Results reported in communities are mixed: some keep testicular size, others do not. hCG acts on the testes directly; gonadorelin depends on a pituitary that TRT is suppressing.
Minutes. Reference works give a distribution half-life of 2 to 10 minutes and a terminal half-life of 10 to 40 minutes. That is why the medical version runs on a pump every 90 to 120 minutes.
Unknown. Gonadorelin clears from blood within minutes, and no study has measured testicular size or sperm on that schedule in men on TRT. The studied regimens are pumps that pulse all day.
Guides disagree. One says never more than 3 days in a row, to avoid desensitizing the pituitary; another runs a 14-day daily course. Pump studies did dose all day, but in small pulses.
With a 2 mg vial and 2 mL of water (1 mg per mL), 100 mcg is 10 units. With a 10 mg vial and 2 mL (5 mg per mL), it is 2 units. Use the calculator for your vial.
By pump, yes, in men and women whose own GnRH is missing. In 28 men with CHH, sperm appeared in 90% on the pump arm. In 12 women with hypothalamic amenorrhea, all ovulated. Shots a few times a week have not been tested for fertility.
The Factrel label calls side effects rare after a single dose: headache, light-headedness, nausea, flushing and injection-site swelling or itch. Rashes came with long-term subQ use, and rare allergic reactions with repeated doses.
Research powder in the fridge or freezer. Once mixed, 2 to 8 C, not frozen, used within 14 to 28 days per guides. The old Factrel label said mix right before use and use within 1 day.
Yes. WADA's 2026 list names GnRH (gonadorelin) and its agonist analogues under S2.2.1, testosterone-stimulating peptides in males.
Two salts of the same peptide. Factrel used the hydrochloride; Lutrepulse used the acetate.
Answers come from this site's pages only, with a link to each source.
21 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.